Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Maesa japonica extracts and methods of use
Placental tissue grafts
Hydrofluorocarbon refrigerant compositions for heat pump water heaters
Wearable display device
Systems and methods for switching supply load current estimation
Vehicle control apparatus
  Randomly Featured Patents
Accelerated weathering apparatus having sealed weathering chamber
Adjustable tree stand
Semiconductor device
Target shooting game
Strontium-apatite cement preparations, cements formed therefrom, and uses thereof
Current limited voltage source with wide input current range
Multi point contactor and blade construction
Data transmitting apparatus data receiving apparatus and data transmission control apparatus
Multiple fiber optic gigabit ethernet links channelized over single optical link
Process to produce carbon nanotubes from microalgae